IP Group has returned for a series B round raised by Ieso Digital Health, having initially acquired stakes in the business through its purchase of Touchstone.

Ieso Digital Health, a UK-based digital therapeutics platform, closed a £39m ($53m) series B round yesterday featuring commercialisation firm IP Group. Morningside led the round, while Sony Innovation Fund, a corporate venturing vehicle for conglomerate Sony, Molten Ventures and Ananda Impact Ventures also participated. Founded in 2000, Ieso Digital Health has developed artificial intelligence (AI)-equipped…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.